2026-10-25
Ralliant clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 28,474 +1.04%
S&P 7,697 +1.70%
GOLD $4,069 +3.25%
BTC $80,060 +3.51%
VIX 16.84 −19.16%
latest tape · as of 20:07 UTC
The Screen · Technology · Electronic Components
Ralliant Corporation
RAL · the NYSE · USD · Market cap $7.4B · 7,000 employees
Ralliant Corporation engages in the design, development, manufacture, sale, and service of precision instruments and engineered products in the United States, China, and internationally.
Not yet scored71.31 USD
Price as of 3 Nov 2026Daily close, not a live quote
Screened 2026-11-03 · the tape above runs as of 20:07 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price71.31 USD at the 3 Nov 2026 close
- Our value readFair vs our fair value, as of 3 Nov 2026
- Our regime readMarkup, as of 2 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans heavily to calls (put/call 0.30)
- Last reviewed3 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $52.20 to $78.96, base estimate $68.66 (screen dated 2026-11-03).
- Trend Markup
- Insiders insiders sold, $913,023, latest filing 2026-10-14
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.30, read 2026-11-03
- Ethical screen not yet scored
Price71.31 USD
Fair value68.66
Ethical score70.0/100
Value readFairas of 3 Nov 2026
Our investment reviews on this name
2026-11-01Read Markup67.21+6.1% to today ✓Distribution gives way to Markup first Markup read since August
2026-10-28Read Distribution66.95+6.5% to today Markdown gives way to Distribution
2026-10-21Read Markdown66.95+6.5% to today Accumulation gives way to Markdown after a 5% slide in 3 weeks
2026-10-02Read Accumulation70.80+0.7% to today ✓Distribution gives way to Accumulation after a 15% rise in 3 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its markup label.
Ralliant Corporation holds its Markup at $71.31. The statistical read favours the sellers, held for 99 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 99 days |
| Price at the screen | $71.31 |
| Valuation | N/A trailing · 19.81 forward price to earnings |
| Values screen | Not scored · score 70.0 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 32.00% | Below 33% | Interest-bearing debt is just 32.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 15.81% | Below 49% | Money owed to the company is 15.8% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Ralliant clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-04. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Ralliant clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 32%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Fair vs our fair value, as of 3 Nov 2026: it trades at roughly a 3% discount to our $68.66 fair value, 12.80% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-03 screen. The gold marker is the market price at the same screen. The price runs 3.9% above the base estimate.
Third-party analyst targets: 11 covering, consensus Buy. The average target sits +12% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $68.66, with a range of $52.20 to $78.96, dated to the 2026-11-03 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsPrecision instruments firm priced above its worth
Picture a supplier of test gear and safety sensors whose products sit in factories and labs worldwide. Revenue is expanding at 11 percent, yet the company reports a negative 59 percent profit margin and negative 46 percent return on equity. With shares trading at 22.8 times forward earnings while our fair value sits 16 percent below the current price, the numbers point to an expensive business rather than an overlooked one.
We pass because the gap between price and fair value leaves no margin of safety. Analyst targets cluster near the current level, but those forecasts sit atop still-negative returns and an unknown competitive position. Ethical checks are clear, yet the financial picture offers no cushion against execution slips or slower demand.
High valuation combined with persistent losses creates the real exposure here. Any revenue slowdown could widen the gap between market price and underlying cash generation. Analysis, not advice.
| Forward P/E | 19.8xpriced for continued growth |
| EPS, trailing | -10.93 |
| EPS, forward | 3.38 |
| Revenue growth | +12.8%steady growth |
| Profit margin | -56.4%currently unprofitable |
| Return on equity | -53.9%not currently earning a positive return on equity |
| FCF yield | 4.51% |
| Dividend yield | 30.00% |
| Debt to equity | 0.80moderate, manageable leverage |
| Current ratio | 1.52healthy short-term liquidity |
| Short interest, float | 0.08% |
| 52-week range | 37.27 - 75.41 |
| Market cap | $7.4B |
| Employees | 7,000 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeRAL trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-04
Markup $71.31
+6.1% Entry 16
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.1% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (11 analysts) rates it buy, with a mean price target of $64. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03
Markup $67.21
+0.0% Entry 15
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (11 analysts) rates it buy, with a mean price target of $64. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02
Markup $67.21
+0.0% Entry 14
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (11 analysts) rates it buy, with a mean price target of $64. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01
Markup · changed $67.21
+1.1% Entry 13
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.1% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (11 analysts) rates it buy, with a mean price target of $64. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31
Distribution $66.49
+0.0% Entry 12
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (11 analysts) rates it buy, with a mean price target of $64. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30
Distribution $66.49
+0.0% Entry 11
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (11 analysts) rates it buy, with a mean price target of $64. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29
Distribution $66.49
-0.7% Entry 10
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (11 analysts) rates it buy, with a mean price target of $64. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28
Distribution · changed $66.95
+0.0% Entry 9
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (11 analysts) rates it buy, with a mean price target of $64. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21
Markdown · changed $66.95
-8.5% Entry 8
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 8.5% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (11 analysts) rates it buy, with a mean price target of $64. Insiders have been net sellers over the past quarter.
2026-10-14
Accumulation $73.20
+3.4% Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (11 analysts) rates it buy, with a mean price target of $64.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Ralliant Declares Regular Quarterly Dividend Yahoo Finance · 5d ago
- Ralliant (RAL) Stock Could Be 23% Overvalued On Cash Flow Grounds Yahoo Finance · 6d ago
- NTTYY or RAL: Which Is the Better Value Stock Right Now? Yahoo Finance · 7d ago
- Ralliant (RAL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Yahoo Finance · 7d ago
- Will Ralliant (RAL) Beat Estimates Again in Its Next Earnings Report? Yahoo Finance · 9d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
PLXSPlexus Corp.
LFUSLittelfuse Inc
SANMSanmina Corp
FNFabrinet
VICRVicor Corp
TTMITTM Technologies Inc
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-14 | Newcombe Tamara S. | Pres, CEO | S - Sale+OE | 12,936 | $913,023 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-09-24 | Maria Elvira Salazar | Republican | sell | 1K–15K |
| 2026-09-21 | Gil Cisneros | Democrat | buy | 1K–15K |
| 2026-09-21 | Gil Cisneros | Democrat | buy | 1K–15K |
| 2026-09-21 | Gil Cisneros | Democrat | buy | 1K–15K |
| 2026-09-14 | Suzan DelBene | Democrat | buy | 250K–500K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $49.52 | +25.8% | $0.05 | $1,259 | +25.9% |
| 2 months | $45.37 | +37.3% | $0.05 | $1,374 | +37.4% |
| 3 months | $42.91 | +45.1% | $0.05 | $1,453 | +45.3% |
| 6 months | $52.12 | +19.5% | $0.10 | $1,197 | +19.7% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever RAL does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.